Rhenman & Partners Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $534K | Sell |
|
|||||
|
2022
Q4 | $2.57M | Hold |
|
|||||
|
2022
Q3 | $3.6M | Buy |
|
|||||
|
2022
Q2 | $2.9M | Sell |
|
|||||
|
2022
Q1 | $4.42M | Sell |
|
|||||
|
2021
Q4 | $5.97M | Hold |
|
|||||
|
2021
Q3 | $6.89M | Hold |
|
|||||
|
2021
Q2 | $9.16M | Hold |
|
|||||
|
2021
Q1 | $9.59M | Sell |
|
|||||
|
2020
Q4 | $12.8M | Buy |
|
|||||
|
2020
Q3 | $6.38M | Hold |
|
|||||
|
2020
Q2 | $6.05M | Sell |
|
|||||
|
2020
Q1 | $4.46M | Hold |
|
|||||
|
2019
Q4 | $5.86M | Sell |
|
|||||
|
2019
Q3 | $6.65M | Sell |
|
|||||
|
2019
Q2 | $8.55M | Sell |
|
|||||
|
2019
Q1 | $8.05M | Sell |
|
|||||
|
2018
Q4 | $12.7M | Sell |
|
|||||
|
2018
Q3 | $20.3M | Buy |
|
|||||
|
2018
Q2 | $14.9M | Buy |
|
|||||
|
2018
Q1 | $4.86M | Hold |
|
|||||
|
2017
Q4 | $4.2M | Buy |
|